Item 303 of SEC Regulation S-K requires companies to disclose “known trends and uncertainties” in certain public filings. In securities class action litigation, plaintiffs increasingly allege the omission of such “known trends and uncertainties” as a basis for liability. But Item 303 provides no private right of action. A private plaintiff can bring an Item 303 action only if there is a separate violation of a securities law for which there is a private right of action. To state a claim under section 11 of the 33 Act, plaintiffs (and courts) rely on a decades-old Ninth Circuit decision, Steckman v. Hart Brewing Co. Steckman held that an Item 303 violation automatically states a claim under section 11, short-circuiting any separate consideration under the statute. This post examines the Steckman decision and contends that it was wrongly decided. Analysis in recent decisions by the U.S. Courts of Appeal for the Second, Third, and Ninth Circuits contradict Steckman’s holding. These courts held that an Item 303 violation does not sufficiently state a claim for liability under section 10(b) of the 34 Act, for the simple reason that Item 303 sets a lower threshold for materiality than 10(b): Item 303 materiality is defined by a “reasonably likely” standard set by the SEC, but 10(b) materiality is subject to a heightened “substantial likelihood” standard set by the U.S. Supreme Court in Basic v. Levinson. This post argues that this materiality distinction applies equally to section 11. Courts agree that an omission under section 11—like section 10(b)—must be material under the heightened Basic standard. Given that (i) an Item 303 violation cannot sufficiently establish Basic materiality, and (ii) Basic materiality is required under section 11, it follows that an Item 303 violation cannot be sufficient to state a claim for liability under Section 11. Steckman should be reconsidered.
Nearly fifty years after Congress enacted the Securities Act of 1933 (33 Act) and the Securities Exchange Act of 1934 (34 Act) (collectively, the securities laws), the Securities and Exchange Commission (SEC) adopted Regulation S-K (Reg. S-K). Reg. S-K provides instructions for companies filing disclosure forms under the securities laws. However, Reg. S-K does not provide a private remedy. A company that omits a Reg. S-K disclosure is subject to liability in a private action only if that omission is actionable under the securities laws. Yet in initial public offering (IPO) litigation across the country, class action plaintiffs—and increasingly courts—view certain Reg. S-K omissions as sufficient to state a claim, without separately analyzing whether the omissions are actionable under the securities laws.
Plaintiffs typically focus on Reg. S-K Item 303’s requirement to disclose known trends and uncertainties. An Item 303 violation is easy to plead, for three reasons. First, a plaintiff need not allege that any disclosed fact was untrue, but simply that a trend or uncertainty was omitted. Second, an Item 303 allegation is inherently speculative—making it harder to dismiss at the pleadings stage before fact discovery—because it calls for hindsight analysis of forward-looking information. In light of negative results that have now come to pass, plaintiffs look back to the time of the offering and assert that the company had enough information then to identify a trend or uncertainty that would have predicted the current results. Finally, Item 303 has a lower materiality threshold than section 10b of the 34 Act (match with defined terms).
In recent years, courts have begun paying close attention to attempts by plaintiffs to leverage Item 303 allegations to state a claim for liability under section 10(b) of the 34 Act.
Less attention has been paid to attempts to leverage Item 303 allegations to state a claim under section 11 of the 33 Act. Many courts assume, with little or no analysis, that an Item 303 violation is automatically sufficient to state a claim. This assumption can be traced to the Ninth Circuit’s “short and cryptic opinion” in Steckman v. Hart Brewing. The Steckman court concluded that “allegations which sufficiently state a claim under Item 303 also state a claim under section 11.”
This view of Item 303 as a surrogate for section 11 has dire consequences for companies and their officers and directors. Item 303’s lower materiality threshold and murky cause of action make it easier to survive dismissal. By viewing an Item 303 violation as actionable under section 11, Steckman opens companies up to costly discovery and “virtually absolute” liability even when the alleged materiality falls below the statutory threshold.
This post contends that Steckman’s conclusion was wrong. To reach it, Steckman ignored statutory language and U.S. Supreme Court precedent. The conclusion was not necessary for its holding. Steckman ignored the parties’ reasoning and distorted their arguments. Its view of materiality is incoherent and unsupported.
Most important, Steckman is contradicted by recent analyses in the U.S. Courts of Appeals for the Ninth, Third, and Second Circuits. These courts hold that an Item 303 violation does not sufficiently state a claim under section 10(b). Their reasoning is straightforward: Item 303 sets a lower threshold for materiality than section 10(b). Under section 10(b), the alleged omission must be material under a heightened “substantial likelihood” standard followed by the Supreme Court in Basic v. Levinson. In contrast, Item 303 materiality is defined by a lower (and different) “reasonably likely” standard set by the SEC. An omission sufficiently material under the lower standard of Item 303 is not necessarily material under the higher standard of section 10(b). Thus, these courts conclude that an Item 303 violation cannot be a surrogate for section 10(b) liability.
By this logic, Item 303 cannot be a surrogate for section 11, either. Courts agree that an omission under section 11—like section 10(b)—must be material under the heightened Basic standard. Given that (i) an Item 303 violation cannot sufficiently establish Basic materiality and (ii) Basic materiality is required under section 11, it follows that an Item 303 violation cannot be sufficient to state a claim for liability under section 11.
The post proceeds as follows: Part II outlines the statutory and regulatory framework. Part III analyzes the arguments and decision in Steckman. Part IV examines three Circuit Court of Appeals decisions rejecting Steckman’s analysis. Part V shows how their reasoning applies with equal force to 33 Act claims. Part VI shows how these courts have struggled to preserve Steckman’s distinction between 34 Act and 33 Act claims and contends that these attempts fail. The post concludes by urging practitioners and courts to reconsider Steckman, following the lead of a 2011 federal district court decision.
II. Statutory and Regulatory Framework
A. Statutory Provisions
Sections 11 and 12 of the 33 Act provide a private remedy to the purchaser of a security in connection with a misleading offering. Section 11 provides a remedy if the security was issued pursuant to a registration statement that “omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading ….” Section 12(a)(2) provides a remedy if the security was offered or sold by means of a prospectus or communication that omitted “to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading ….”
Section 10(b) of the 34 Act makes it unlawful to sell securities using “any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe as necessary or appropriate in the public interest or for the protection of investors.” The SEC implemented section 10(b) by promulgating Rule 10b-5. The rule makes it unlawful “to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading ….” Although neither section 10(b) nor Rule 10b-5 contains an express private remedy, courts have “implied a private cause of action from the text and purpose of [section] 10(b).”
B. Reg. S-K Item 303
Item 303 requires companies to include in certain public filings management’s discussion and analysis of their financial condition and results of operations (MD&A). Among numerous MD&A line item disclosures, one frequently asserted by plaintiffs is the requirement to “[d]escribe any known trends or uncertainties that have had or that the registrant reasonably expects will have a material favorable or unfavorable impact on net sales or revenues or income from continuing operations.”
C. Contrasting Statutory Materiality with Item 303 Materiality
Both the securities laws and Item 303 contain a materiality requirement. However, the standard for materiality under these two varies.
1. Securities Laws
Materiality of an omission for purposes of liability under the securities laws is subject to a “substantial likelihood” standard set by the U.S. Supreme Court. In Basic v. Levinson, the Court “expressly adopt[ed]” the materiality standard defined in the Court’s 1976 decision TSC v. Northway:
An omitted fact is material if there is a substantial likelihood that a reasonable shareholder would consider it important …. [To establish materiality,] there must be a substantial likelihood that the disclosure of the omitted fact would have been viewed by a reasonable investor as having significantly altered the ‘total mix’ of information made available.
Basic noted that “with respect to contingent or speculative information or events, … materiality ‘will depend at any given time upon a balancing of both the indicated probability that the event will occur and the anticipated magnitude of the event in light of the totality of the company activity.’”
Though Basic involved 34 Act claims, courts have made clear that the Basic standard applies to 33 Act claims as well.
2. Item 303
By contrast, materiality under Item 303 is subject to a “reasonably likely” standard set by the SEC:
Where a trend, demand, commitment, event or uncertainty is known, management must make two assessments:
- Is the known trend, demand, commitment, event or uncertainty likely to come to fruition? If management determines that it is not reasonably likely to occur, no disclosure is required.
- If management cannot make that determination, it must evaluate objectively the consequences of the known trend, demand, commitment, event or uncertainty, on the assumption that it will come to fruition. Disclosure is then required unless management determines that a material effect on the registrant’s financial condition or results of operations is not reasonably likely to occur.
The SEC has expressly distinguished the Item 303 standard from the Basic standard:
[Item 303] mandates disclosure of specified forward-looking information, and specifies its own standard for disclosure, i.e., reasonably likely to have a material effect. This specific standard governs the circumstances in which Item 303 requires disclosure. The probability/magnitude test for materiality approved by the Supreme Court in Basic Inc. v. Levinson, 108 S. Ct. 978 (1986), is inapposite to Item 303 disclosure.
III. Steckman v. Hart Brewing
In Steckman, shareholder Jeffrey Steckman brought a class action on behalf of shareholders against Hart Brewing, a craft brewery, six months after it went public. The complaint alleged that Hart Brewing’s IPO registration statement contained omissions under sections 11 and 12(a)(2) of the 33 Act. According to the complaint, the company “knew that a plateau in sales and earnings had been reached” prior to the IPO, “and that subsequent quarters would experience declining sales.” Steckman contended that this was a known “adverse trend” required to be disclosed under Item 303. The district court found no Item 303 violation and dismissed the action.
On appeal, the defendants maintained that Item 303 had not been violated. In addition, the underwriter defendants raised a new argument in the alternative: even if, arguendo, Item 303 had been violated, that “would not be sufficient to state a cause of action under the  Act.”
A. The Underwriters’ New Argument
The underwriters noted that the Basic test governs materiality under section 11. They then distinguished the Basic test from the materiality test under Item 303. The underwriters concluded that, in light of Item 303’s different (and lower) threshold for materiality, it could not serve as a surrogate for liability under section 11: “[b]ecause the SEC and Section 11 employ different standards for determining when required information is ‘material[,]’ … it is inevitable that their disclosure obligations cannot be used interchangeably.”
The underwriters also quoted Alfus v. Pyramid, a federal district court decision. Alfus held that the “demonstration of a violation of the disclosure requirements of Item 303 does not lead inevitably to the conclusion that such disclosure would be required under Rule 10b-5[, which, like section 11, applies the Basic materiality standard]. Such a duty to disclose must be separately shown.”
B. Steckman’s Reply
In his reply, Steckman did not dispute the underwriters’ central argument. He did not contend that even if Item 303 materiality is subject to a lower threshold than section 11, it could nonetheless be a surrogate for section 11 liability. Instead, he objected to the premise; he argued that Item 303 materiality and statutory materiality are in fact interchangeable: “the general standards of materiality set forth in TSC, Basic [(section 10(b))], and Worlds of Wonder [section 11] do apply to Item 303.”
C. The Ninth Circuit’s Ruling
The Ninth Circuit affirmed the district court’s finding that Steckman “ha[d] failed to state a claim under Item 303.” It did not need to pass on the underwriters’ new argument in the alternative, had an Item 303 violation been established. Yet the court chose to address the “threshold issues” raised by the underwriters’ new argument.
In a “short and cryptic opinion,” the Steckman court held that Item 303 can be a surrogate for liability under the 33 Act, but not the 34 Act. This result was advocated by neither party. The court did not weigh in on the central question in dispute: whether Item 303 materiality is interchangeable with Basic materiality. Instead, it adopted a position presented by neither party, contrary to precedent and statute: neither Item 303 nor section 11 require Basic materiality. Steckman’s holding has three components: an Item 303 violation is (1) a surrogate for section 11 liability, (2) a surrogate for section 12(a)(2) liability, and (3) not a surrogate for section 10(b) liability. Each will be analyzed in turn.
1. Surrogate for Section 11 Liability
First, the court asserted that “allegations which sufficiently state a claim under Item 303[(a) of Regulation S-K] also state a claim under section 11”:
Form S-1, which [the company] used in its registration, requires the registrant to follow Item 303. There is liability under section 11 if a registrant ‘omit[s] to state a material fact required to be stated’ in the registration statement. See section 11(a). Therefore, any omission of facts ‘required to be stated’ under Item 303 will produce liability under Section 11.
The court here took the position—not taken by either party—that the mere omission of a fact that the company had a legal duty to disclose states a claim for liability under section 11.
2. Surrogate for Section 12(a)(2) Liability
The Steckman court then extended its conclusion to section 12(a)(2): “[a]llegations which would support a claim under Item 303 are sufficient to support a claim under [s]ection 12(a)(2).”
This position—suggested by neither party—is even more problematic. The “required to be stated” language central to the court’s analysis of section 11 is absent from section 12(a)(2).
Steckman’s ultimate conclusion, then, is that materiality under the securities laws is presumed simply by the fact that the company omitted a disclosure “mandated by law,” including by SEC regulation. This is essentially the same result the court articulated under section 11, but now the court labels this as material. As discussed, such a result was advocated by neither party and leads to absurd results. Steckman’s presumption of materiality ignores Supreme Court jurisprudence defining heightened materiality under the securities laws.
3. Not a Surrogate for Section 10(b) Liability
The Steckman court limited its conclusion to 33 Act claims. With respect to 34 Act claims, however, the court conceded that Item 303 is not a surrogate for liability. The court offered one sentence of explanation: “Section 10(b) of the Exchange Act, which has only an implied right of action, differs significantly from Sections 11 and 12(a)(2) of the Securities Act, which have express rights of action.”
Why should that matter? As one commentator has pointed out, “none of the courts rejecting Item 303 as a basis for Rule 10b-5 liability mentioned the implied nature of the cause of action as being a factor.” The court’s distinction has no basis in case law or legislative history. Though the remedy for section 10(b) is implied, its standard for liability is defined in identical terms to section 12(a)(2), for which the court just held Item 303 is a surrogate. Further, the Ninth, Third, and Second Circuits all hold that the same materiality standard applies to both 33 Act and 34 Act claims. If materiality can be presumed, liability should follow, whether the cause of action is express or implied.
For all of these reasons, Steckman was wrongly decided.
IV. The Underwriters’ Argument is Adopted by the Third, Ninth, and Second Circuits
Since Steckman, at least three federal Courts of Appeal have come to endorse the underlying argument made by Hart Brewing’s underwriters distinguishing Item 303 materiality from Basic materiality.
A. Third Circuit
In Oran v. Stafford, shareholders brought a class action against a drug manufacturer, alleging 34 Act violations for not “disclos[ing] several studies linking the drugs to heart-valve damage.” The district court dismissed for failure to state a claim. On appeal, the plaintiffs argued that by not disclosing the alleged “link between its drugs and valvular heart disorder,” the company violated Item 303’s requirement to disclose “known trends and uncertainties,” and that “such a violation can support a claim under [the 34 Act].”
Then-Judge Alito explained that to prevail, plaintiffs had to show “either that [Item] 303 creates an independent private right of action, or that the regulation imposes an affirmative duty of disclosure on [the company] that, if violated, would constitute a material omission under Rule 10b-5.”
After holding that Item 303 does not create a private right of action, the court proceeded to analyze plaintiffs’ contention that a violation of Item 303 constitutes a material omission under the securities laws. In the court’s view, the critical question was the same question identified three years earlier by the Steckman underwriters (but ignored by the Steckman court): “whether the disclosure mandated by [Item] 303 is governed by standards consistent with those that the Supreme Court has imposed for private fraud actions under the federal securities laws.”
Oran began by quoting the SEC’s two-part “reasonably likely” materiality standard that “characterized a company’s disclosure obligations under [Item] 303.” It then contrasted that with the materiality standard under the securities laws:
[T]he general test for securities fraud materiality [was] set out by the Supreme Court in Basic, Inc. v. Levinson, which premised forward-looking disclosure ‘upon a balancing of both the indicated probability that the event will occur and the anticipated magnitude of the event in light of the totality of the company activity.’
The Third Circuit concluded, like the Steckman underwriters, that the standards “var[y] considerably.” Specifically, “[Item] 303’s disclosure obligations extend considerably beyond those required by Rule 10b-5.” “Because the materiality standards for Rule 10b-5 and [Item] 303 differ significantly,” Item 303 cannot be a surrogate for section 10(b) or Rule 10b-5. Thus, “a violation of [Item] 303’s reporting requirements does not automatically give rise to a material omission under Rule 10b-5.”
B. Ninth Circuit
The question of Item 303 as a surrogate for federal securities claims did not again come before the Ninth Circuit until 2014, sixteen years after Steckman. Shareholders brought a securities class action under the 34 Act against semiconductor manufacturer NVIDIA for not disclosing alleged product defects. The district court dismissed the claims for failure to plead scienter. On appeal, plaintiffs contended that “the district court’s analysis should have focused on whether NVIDIA acted with scienter in failing to make the Item 303 disclosure.”
In its opinion, the Ninth Circuit noted that it had “never directly decided whether Item 303’s disclosure duty is actionable under Section 10(b) and Rule 10b-5. We now hold that it is not.” In reaching this holding, the court followed Oran: “In Oran v. Stafford, the Third Circuit decided this issue more directly. We are persuaded by its reasoning.”
After analyzing the materiality tests under Item 303 and Basic, NVIDIA determined, as did Oran and the Steckman underwriters, that “these two standards differ considerably”:
Management’s duty to disclose under Item 303 is much broader than what is required under the standards pronounced in Basic. … The SEC’s effort to distinguish Basic’s materiality test from Item 303’s disclosure requirement provides further support for the position that Item 303 requires more than Basic—what must be disclosed under Item 303 is not necessarily required under the standard in Basic. Therefore, … the ‘demonstration of a violation of the disclosure requirements of Item 303 does not lead inevitably to the conclusion that such disclosure would be required under Rule 10b-5.’
C. Second Circuit
In Stratte-McClure, shareholders brought a putative class action under the 34 Act against Morgan Stanley for alleged misstatements and omissions regarding its exposure to subprime mortgages. The plaintiffs alleged that Morgan Stanley should have disclosed its exposure earlier as a “known trend or uncertaint[y]” under Item 303 that had or was “reasonably expected to have an unfavorable material effect on revenue.” The district court “ruled that Morgan Stanley did have a duty [to disclose] under Item 303.” It found further that the “alleged disregard of Item 303 of Regulation S-K, constituted an actionable omission under Section 10(b) and Rule 10b-5.” But the district court dismissed the claim for failure “to plead ‘a strong inference of scienter.’” The Second Circuit affirmed:
We conclude, as a matter of first impression in this Court, that a failure to make a required Item 303 disclosure in a 10-Q filing is indeed an omission that can serve as the basis for a Section 10(b) securities fraud claim. However, such an omission is actionable only if it satisfies the materiality requirements outlined in Basic Inc. v. Levinson, and if all of the other requirements to sustain an action under Section 10(b) are fulfilled. Here, the district court properly dismissed Plaintiffs’ exposure claim predicated on Morgan Stanley’s failure to disclose under Item 303 because the second amended complaint did not sufficiently plead scienter.
The Second Circuit further broke down its analysis. It first acknowledged that “Item 303 imposes the type of duty to speak that can, in appropriate cases, give rise to liability under Section 10(b).” But then it clarified: “The failure to make a required disclosure under Item 303, however, is not by itself sufficient to state a claim for securities fraud under Section 10(b). Significantly, Rule 10b-5 makes only ‘material’ omissions actionable.”
The Second Circuit went on to draw the same contrast shown by the Steckman underwriters, the Third Circuit in Oran, and the Ninth Circuit in NVIDIA. It contrasted the Basic test with the SEC’s “two-part (and different) inquiry” that determines a “duty to report under Item 303.” It noted—as did the Steckman underwriters, Oran, and NVIDIA—that the SEC has itself stated that “this disclosure standard is unique to Item 303,” and “is inapposite” to Basic materiality. The court then adopted Oran’s conclusion that “Item 303’s disclosure obligations ‘extend considerably beyond those required by Rule 10b-5’”:
Since the Supreme Court’s interpretation of ‘material’ in Rule 10b-5 dictates whether a private plaintiff has properly stated a claim, we conclude that a violation of Item 303’s disclosure requirements can only sustain a claim under Section 10(b) and Rule 10b-5 if the allegedly omitted information satisfies Basic’s test for materiality.
Thus, the Second Circuit joined the Third and Ninth in embracing the Steckman underwriters’ distinction of Item 303 materiality from Basic materiality. For this reason, these courts hold that Item 303 cannot be a surrogate for section 10(b) liability.
V. Because 33 Act Claims are Governed by Basic They Cannot Be Distinguished From 34 Act Claims
The position of the Steckman underwriters, Oran, NVIDIA, and Stratte-McClure cannot logically be contained to claims under the 34 Act. The reason is simple: these courts agree that Basic materiality—and not the SEC’s broader Item 303 test—governs 33 Act claims. Just as Item 303 is not sufficient to state a section 10(b) claim because it is subject to the heightened Basic standard, for the same reason Item 303 cannot be sufficient to state a claim under section 11.
This result is not only logical, but also supported by the Court’s reasoning in Basic. The Basic Court explained that it deliberately raised the materiality standard:
Acknowledging that certain information concerning corporate developments could well be of ‘dubious significance,’ the Court was careful not to set too low a standard of materiality; it was concerned that a minimal standard might bring an overabundance of information within its reach, and lead management ‘simply to bury the shareholders in an avalanche of trivial information—a result that is hardly conducive to informed decisionmaking.’
This rationale applies with equal (if not stronger) force to section 11. Disclosures pose the same risk of “burying the shareholders in an avalanche of trivial information” whether they are subject to challenge under section 11 or section 10(b). Moreover, the “interrorem nature” of section 11’s “virtually absolute” strict liability (which, unlike section 10(b), has no scienter requirement) makes it even more likely to spur excessive disclosure. Were Basic applied only to section 10(b) claims and not section 11, its purpose would be defeated: the specter of section 11’s strict liability would still induce issuers to bury investors in trivial information.
VI. Attempts to Distinguish 33 Act Claims Fail
Not wishing to overrule Steckman, the Oran and NVIDIA courts attempt to confine their holding to 34 Act claims. These attempts—which are mere dicta—fail.
A. Reliance on Steckman is Misplaced
Oran assumes in a footnote that section 11 claims are different simply because Steckman says so. It neither engages with Steckman’s rationale nor offers any basis for such distinction. Likewise, NVIDIA begins by noting that, “as we acknowledged in [Steckman], ‘section 10(b) of the Exchange Act … differs significantly from sections 11 and 12(a)(2) of the Securities Act.’”
These courts’ reliance on Steckman is misplaced (putting aside that Steckman was wrongly decided). Unlike these courts, Steckman never adopted the argument that Item 303 is not sufficient to state a claim requiring Basic materiality. Thus Steckman was able to hold that Item 303 could be interchangeable with, and a surrogate for, section 11. In contrast, these courts have all embraced the argument—ignored by Steckman—that Item 303 and Basic (which applies to section 11) are not interchangeable. Arguably, the Steckman court itself would never have distinguished 33 Act claims had it adopted the underwriters’ insufficiency argument as do these courts. These courts’ adoption of the underwriters’ argument effectively overrules Steckman’s conclusion.
B. Distinction Based on Statutory Language Fails
The NVIDIA court attempts to distinguish 33 Act claims based on purported differences in statutory language: “[l]iability under sections 11 and 12(a)(2) of the Securities Act may arise from ‘omit[ting] to state a material fact required to be stated.’ … There is no such requirement under section 10(b) or Rule 10b-5.” As the Second Circuit pointed out, however, this misreads the statute: “section 12(a)(2)’s prohibition on omissions is textually identical to that of Rule 10b-5….”
C. 33 Act Materiality is Set by Basic even after Matrixx
NVIDIA cites the Second Circuit’s decision in Panther Partners that “[33 Act] liability arises from ‘an omission in contravention of an affirmative legal disclosure obligation,’” and contrasts that with 34 Act liability as defined in Matrixx. If the court means, like Steckman, that there is no materiality requirement for 33 Act claims, this reads materiality out of the statute and suffers the same ills as Steckman. The more plausible reading is that 33 Act claims have a lower materiality standard than 34 Act claims. But this is contradicted by the Second Circuit’s statement in Blackstone that “the test for materiality is the same [under section 10(b) as] when claims are brought pursuant to sections 11 and 12(a)(2) ….” Further, neither Blackstone nor Panther Partners state that section 12(a)(2) has a lower materiality standard than section 10(b).
Moreover, even were it true that after Matrixx, materiality under the 34 Act is higher than under the 33 Act, that still does not reduce 33 Act claims from the Basic materiality threshold, which is itself a higher standard than under Item 303. Matrixx stated that under section 10(b), even “material information need not be disclosed unless omission of that information would cause other information that is disclosed to be misleading.” But Matrixx did not address section 11. Nothing in Matrixx overrules the well-settled appellate jurisprudence that Basic materiality applies equally to section 11 and section 10(b) claims. Indeed, Matrixx reaffirms Basic as the baseline standard for materiality. At most, Matrixx sets the bar for 34 Act omissions higher than the Basic standard. It does nothing to lower the standard for section 11. Section 11 remains subject to Basic materiality, which is not interchangeable with Item 303 materiality.
D. Differences Regarding Scienter and Pleading Requirements are Irrelevant
NVIDIA proffers a seemingly meaningless distinction: 33 Act claims are different because “scienter is not an element.” Scienter is not an element, but materiality is. And materiality is governed by Basic which is higher than Item 303 materiality, which makes it impossible for an Item 303 violation to automatically trigger section 11 liability. This same logic applies to NVIDIA’s purported distinction on the grounds that 33 Act claims are “not subject to the PSLRA’s heightened pleading standards.”
E. The Second Circuit’s “Two-Step” Approach
Recent Second Circuit decisions may reject surrogate liability with respect to both 33 Act and 34 Act claims.
The Second Circuit recognizes two discrete elements in establishing an omission under the securities laws: (1) a duty to disclose and (2) a material omission. An Item 303 violation “establishes that the defendant had a duty to disclose. A plaintiff must then allege that the omitted information was material under Basic’s probability/magnitude test.” An omission required under Item 303 may still not be actionable under the securities laws if not material under Basic. Although Stratte-McClure focuses on 34 Act claims, this two-step approach may apply to 33 Act claims as well. If so, Item 303 would not be sufficient to state a claim under section 11.
Steckman’s conclusion that Item 303 is a surrogate for section 11 liability is worth reconsidering. Its conclusion was not necessary for its holding. Further, Steckman has been effectively overruled. The widespread rejection of Item 303 as a surrogate for Basic materiality makes clinging to Steckman indefensible. Misplaced reliance on Steckman end runs the Supreme Court’s carefully calibrated materiality standards. It promotes excessive disclosure and frivolous litigation.
Instead, courts should side with the Steckman underwriters and the reasoning in NVIDIA, Oran, and Stratte-McClure—and follow that reasoning to its inexorable conclusion: 33 Act claims, like 34 Act claims, cannot sufficiently be established by an Item 303 violation. Such an approach will restore the careful balance struck by the Supreme Court in Basic, benefiting both issuers and investors with more substantive disclosures and less meritless litigation.
The break with Steckman has already begun. In In re Thornburg Mortgage Securities Litigation, the federal district court left open the possibility that Item 303 is not a surrogate for section 11. Where plaintiffs did not “establish a violation of Item 303,” the court expressly declined to “decide whether every violation [of Item 303] is necessarily also a violation of section 11.”
Securities litigators and judges—that’s your cue.